$17.48
-0.085-0.48%
Last update: Dec 11, 1:09 PM
Comments
Loading...
Denali Therapeutics Stock Guidance | NASDAQ:DNLI | Benzinga
Denali Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
FAQ
What is the most recent guidance for Denali Therapeutics (DNLI)?
There have been no specific sales or earnings guidance reported for Denali Therapeutics in recent months.
Browse guidance and forecast on all stocks.
